Features | Unmatched cohort | Matched cohort | ||||
---|---|---|---|---|---|---|
Female patients (n = 26) | Male patients (n = 223) | p value | Female patients (n = 26) | Male patients (n = 26) | p value | |
Duration of ICU stay, hours, median (IQR) | 8 (4–20) | 4 (4–6) | 0.002 | 8 (4–20) | 4 (4–6) | 0.065 |
Hospital stay, days, median (IQR) | 2 (2–3) | 2 (1–4) | 0.950 | 2 (2–3) | 2 (2–4) | 0.802 |
Early mortality | 2 (7.7) | 2 (0.9) | 0.055 | 2 (7.7) | 0 | 0.490 |
Endoleak | 5 (19.2) | 32 (14.3) | 0.558 | 5 (19.2) | 6 (23.1) | 0.734 |
Type 1A | 0 | 3 (1.3) | 0 | 0 | ||
Type 1B | 1 (3.8) | 5 (2.2) | 1 (3.8%) | 1 (3.8) | ||
Type 2 | 3 (11.5) | 15 (6.7) | 3 (11.5) | 3 (11.5) | ||
Type 3 | 1 (3.8) | 8 (3.6) | 1 (3.8) | 2 (7.7) | ||
Secondary intervention | 3 (11.5) | 20 (9.0) | 0.718 | 3 (11.5) | 2 (7.7) | 1.000 |
All-cause mortality | 2 (7.7) | 36 (16.1) | 0.388 | 2 (7.7) | 3 (11.5) | 1.000 |
Follow-up, months, median (IQR) | 26 (14–38) | 25 (14–39) | 0.950 | 26 (14–38) | 27 (13–35) | 0.722 |